Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma
Clinical trial NCT00227669 · COMPLETED
Trial details
- NCT number
- NCT00227669
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2010-02-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.